Ixj: Pure Pharma Against—A Global Healthcare Bet Today
Two popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
Gain insights into the cash back credit card payout process to understand how and when you’ll receive your rewards.
13,581 articlesTwo popular ETFs populate the healthcare investing scene: PPH focuses narrowly on drugmakers, while IXJ spans the bro...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Investors are seeing renewed momentum in xanadu quantum technologies stock as talk of government support and industry...
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
Despite regulatory progress and new market access, XRP has struggled to break out in 2026. This piece analyzes whethe...
Bank of America's Vivek Arya sees Nvidia climbing to $350 as AI-driven demand sustains a broad, structural shift in c...
When a company’s CFO reports a large stock sale, investors want to know what it implies. This article breaks down the...
Georgia and Tether announce a plan to deploy GEL₮, a stablecoin tied to the Georgian lari, designed to ride private p...
Bitget unveils Reality, a new tokenization platform delivering tokenized access to select U.S. stocks and ETFs as mar...
Four major tech players are pouring hundreds of billions into AI infrastructure in 2026 while trimming payrolls. Mean...
SpaceX’s latest IPO disclosures raise a rare self‑awareness moment: its own push for a crowded Low Earth Orbit could ...
Solana’s network momentum is rising in early 2026, yet a persistent FTX estate overhang and waning ETF inflows keep t...